Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cell cycle control by a methylation-phosphorylation switch.

Literature DB >> 21311233

Cell cycle control by a methylation-phosphorylation switch.

Simon M Carr, Nicholas B La Thangue.

Abstract

Mesh：

Substances：

Year: 2011 PMID： 21311233 PMCID： PMC3100787 DOI： 10.4161/cc.10.5.14958

Source DB: PubMed Journal: Cell Cycle ISSN： 1551-4005 Impact factor: 4.534

× No keyword cloud information.

13 in total

Review 1. Cell-cycle inhibitors: three families united by a common cause.

Authors: A Vidal; A Koff
Journal: Gene Date: 2000-04-18 Impact factor: 3.688

Review 2. The diverse functions of histone lysine methylation.

Authors: Cyrus Martin; Yi Zhang
Journal: Nat Rev Mol Cell Biol Date: 2005-11 Impact factor: 94.444

Review 3. Control of pRB phosphorylation.

Authors: S Mittnacht
Journal: Curr Opin Genet Dev Date: 1998-02 Impact factor: 5.578

Review 4. The retinoblastoma protein and cell cycle control.

Authors: R A Weinberg
Journal: Cell Date: 1995-05-05 Impact factor: 41.582

5. Cyclin C/cdk3 promotes Rb-dependent G0 exit.

Authors: Shengjun Ren; Barrett J Rollins
Journal: Cell Date: 2004-04-16 Impact factor: 41.582

Review 6. Protein methylation: a new mechanism of p53 tumor suppressor regulation.

Authors: A Scoumanne; X Chen
Journal: Histol Histopathol Date: 2008-09 Impact factor: 2.303

7. Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein.

Authors: Simon M Carr; Shonagh Munro; Benedikt Kessler; Udo Oppermann; Nicholas B La Thangue
Journal: EMBO J Date: 2010-11-30 Impact factor: 11.598

8. Acetylation control of the retinoblastoma tumour-suppressor protein.

Authors: H M Chan; M Krstic-Demonacos; L Smith; C Demonacos; N B La Thangue
Journal: Nat Cell Biol Date: 2001-07 Impact factor: 28.824

9. DNA-damage-responsive acetylation of pRb regulates binding to E2F-1.

Authors: Douglas Markham; Shonagh Munro; Judith Soloway; Darran P O'Connor; Nicholas B La Thangue
Journal: EMBO Rep Date: 2006-02 Impact factor: 8.807

Review 10. E2F and cell cycle control: a double-edged sword.

Authors: Craig Stevens; Nicholas B La Thangue
Journal: Arch Biochem Biophys Date: 2003-04-15 Impact factor: 4.013

4 in total

1. MBTD1 is associated with Pr-Set7 to stabilize H4K20me1 in mouse oocyte meiotic maturation.

Authors: Yi-Bo Luo; Jun-Yu Ma; Qing-Hua Zhang; Fei Lin; Zhong-Wei Wang; Lin Huang; Heide Schatten; Qing-Yuan Sun
Journal: Cell Cycle Date: 2013-03-08 Impact factor: 4.534

2. Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma.

Authors: Yuelong Liang; Jiang Chen; Qingsong Yu; Tong Ji; Bin Zhang; Junjie Xu; Yi Dai; Yangyang Xie; Hui Lin; Xiao Liang; Xiujun Cai
Journal: Cancer Med Date: 2017-10-13 Impact factor: 4.452

3. Revealing inhibition difference between PFI-2 enantiomers against SETD7 by molecular dynamics simulations, binding free energy calculations and unbinding pathway analysis.

Authors: Yuzhen Niu; Danfeng Shi; Lanlan Li; Jingyun Guo; Huanxiang Liu; Xiaojun Yao
Journal: Sci Rep Date: 2017-04-18 Impact factor: 4.379

4. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.

Authors: Hong Ding; Wen Chao Lu; Jun Chi Hu; Yu-Chih Liu; Chen Hua Zhang; Fu Lin Lian; Nai Xia Zhang; Fan Wang Meng; Cheng Luo; Kai Xian Chen
Journal: Molecules Date: 2018-03-02 Impact factor: 4.411

4 in total